Literature DB >> 18794538

Progress in cancer care: the hope, the hype, and the gap between reality and perception.

Leonard B Saltz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18794538     DOI： 10.1200/JCO.2008.17.6198

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  The value of progression-free survival to patients with advanced-stage cancer.

Authors:  Lesley J Fallowfield; Anne Fleissig
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

2.  Approvals in 2016: questioning the clinical benefit of anticancer therapies.

Authors:  Christopher M Booth; Joseph C Del Paggio
Journal:  Nat Rev Clin Oncol       Date:  2017-02-20       Impact factor: 66.675

3.  Erratum to: Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-07       Impact factor: 9.261

4.  Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.

Authors:  Rainer Souchon; Michael Hartmann; Susanne Krege; Anja Lorch; Frank Mayer; Maria De Santis; Silke Gillessen; Jörg Beyer; Richard Cathomas
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

5.  Approach to the treatment of multiple myeloma: a clash of philosophies.

Authors:  S Vincent Rajkumar; Gösta Gahrton; P Leif Bergsagel
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

Review 6.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

7.  Advances in cancer therapeutics.

Authors:  A Sparreboom; J Verweij
Journal:  Clin Pharmacol Ther       Date:  2009-02       Impact factor: 6.875

Review 8.  [Stage-specific treatment for testicular germ cell tumours].

Authors:  A Heidenreich; C Bokemeyer; R Souchon
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

Review 9.  Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?

Authors:  Courtney Davis
Journal:  Soc Sci Med       Date:  2014-12-02       Impact factor: 4.634

10.  Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

Authors:  Evangelos Briasoulis; Gerasimos Aravantinos; George Kouvatseas; Periklis Pappas; Eirini Biziota; Ioannis Sainis; Thomas Makatsoris; Ioannis Varthalitis; Ioannis Xanthakis; Antonios Vassias; George Klouvas; Ioannis Boukovinas; George Fountzilas; Kostantinos N Syrigos; Haralambos Kalofonos; Epaminontas Samantas
Journal:  BMC Cancer       Date:  2013-05-29       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.